These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 16310959

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Neuroactive steroids in depression and anxiety disorders: clinical studies.
    Eser D, Schüle C, Baghai TC, Romeo E, Rupprecht R.
    Neuroendocrinology; 2006; 84(4):244-54. PubMed ID: 17159334
    [Abstract] [Full Text] [Related]

  • 3. Neuroactive steroids and affective disorders.
    Eser D, Schüle C, Baghai TC, Romeo E, Uzunov DP, Rupprecht R.
    Pharmacol Biochem Behav; 2006 Aug; 84(4):656-66. PubMed ID: 16831459
    [Abstract] [Full Text] [Related]

  • 4. Stress responsive neurohormones in depression and anxiety.
    Ströhle A, Holsboer F.
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S207-14. PubMed ID: 14677081
    [Abstract] [Full Text] [Related]

  • 5. Neuroactive steroids as modulators of depression and anxiety.
    Eser D, Romeo E, Baghai TC, Schüle C, Zwanzger P, Rupprecht R.
    Expert Rev Endocrinol Metab; 2006 Jul; 1(4):517-526. PubMed ID: 30290461
    [Abstract] [Full Text] [Related]

  • 6. Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties.
    Rupprecht R.
    Psychoneuroendocrinology; 2003 Feb; 28(2):139-68. PubMed ID: 12510009
    [Abstract] [Full Text] [Related]

  • 7. Neuropsychopharmacological properties of neuroactive steroids in depression and anxiety disorders.
    Eser D, Schüle C, Romeo E, Baghai TC, di Michele F, Pasini A, Zwanzger P, Padberg F, Rupprecht R.
    Psychopharmacology (Berl); 2006 Jun; 186(3):373-87. PubMed ID: 16247651
    [Abstract] [Full Text] [Related]

  • 8. Neuroactive steroids in affective disorders: target for novel antidepressant or anxiolytic drugs?
    Schüle C, Eser D, Baghai TC, Nothdurfter C, Kessler JS, Rupprecht R.
    Neuroscience; 2011 Sep 15; 191():55-77. PubMed ID: 21439354
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Influence of mirtazapine on plasma concentrations of neuroactive steroids in major depression and on 3alpha-hydroxysteroid dehydrogenase activity.
    Schüle C, Romeo E, Uzunov DP, Eser D, di Michele F, Baghai TC, Pasini A, Schwarz M, Kempter H, Rupprecht R.
    Mol Psychiatry; 2006 Mar 15; 11(3):261-72. PubMed ID: 16344854
    [Abstract] [Full Text] [Related]

  • 11. Plasma concentrations of neuroactive steroids before and after electroconvulsive therapy in major depression.
    Baghai TC, di Michele F, Schüle C, Eser D, Zwanzger P, Pasini A, Romeo E, Rupprecht R.
    Neuropsychopharmacology; 2005 Jun 15; 30(6):1181-6. PubMed ID: 15702138
    [Abstract] [Full Text] [Related]

  • 12. Neuroactive steroids as endogenous modulators of anxiety.
    Eser D, Baghai TC, Schüle C, Nothdurfter C, Rupprecht R.
    Curr Pharm Des; 2008 Jun 15; 14(33):3525-33. PubMed ID: 19075729
    [Abstract] [Full Text] [Related]

  • 13. Changes in CCK-4 induced panic after treatment with the GABA-reuptake inhibitor tiagabine are associated with an increase in 3alpha,5alpha-tetrahydrodeoxycorticosterone concentrations.
    Zwanzger P, Eser D, Romeo E, di Michele F, Baghai TC, Pasini A, Padberg F, Rupprecht R.
    Psychoneuroendocrinology; 2009 Nov 15; 34(10):1586-9. PubMed ID: 19501468
    [Abstract] [Full Text] [Related]

  • 14. Differential modulation of the gamma-aminobutyric acid type C receptor by neuroactive steroids.
    Morris KD, Moorefield CN, Amin J.
    Mol Pharmacol; 1999 Oct 15; 56(4):752-9. PubMed ID: 10496958
    [Abstract] [Full Text] [Related]

  • 15. Induced panic attacks shift gamma-aminobutyric acid type A receptor modulatory neuroactive steroid composition in patients with panic disorder: preliminary results.
    Ströhle A, Romeo E, di Michele F, Pasini A, Hermann B, Gajewsky G, Holsboer F, Rupprecht R.
    Arch Gen Psychiatry; 2003 Feb 15; 60(2):161-8. PubMed ID: 12578433
    [Abstract] [Full Text] [Related]

  • 16. Neuroactive steroids in responders and nonresponders to sleep deprivation.
    Schüle C, Di Michele F, Baghai T, Romeo E, Bernardi G, Zwanzger P, Padberg F, Pasini A, Rupprecht R.
    Ann N Y Acad Sci; 2004 Dec 15; 1032():216-23. PubMed ID: 15677414
    [Abstract] [Full Text] [Related]

  • 17. GABA(A) receptor-modulating neuroactive steroid composition in patients with panic disorder before and during paroxetine treatment.
    Ströhle A, Romeo E, di Michele F, Pasini A, Yassouridis A, Holsboer F, Rupprecht R.
    Am J Psychiatry; 2002 Jan 15; 159(1):145-7. PubMed ID: 11772707
    [Abstract] [Full Text] [Related]

  • 18. Panic induction with cholecystokinin-tetrapeptide (CCK-4) Increases plasma concentrations of the neuroactive steroid 3alpha, 5alpha tetrahydrodeoxycorticosterone (3alpha, 5alpha-THDOC) in healthy volunteers.
    Eser D, di Michele F, Zwanzger P, Pasini A, Baghai TC, Schüle C, Rupprecht R, Romeo E.
    Neuropsychopharmacology; 2005 Jan 15; 30(1):192-5. PubMed ID: 15467707
    [Abstract] [Full Text] [Related]

  • 19. Neurosteroids and neuroactive drugs in mental disorders.
    Pisu MG, Serra M.
    Life Sci; 2004 May 14; 74(26):3181-97. PubMed ID: 15094320
    [Abstract] [Full Text] [Related]

  • 20. Relevance of endogenous 3alpha-reduced neurosteroids to depression and antidepressant action.
    Uzunova V, Sampson L, Uzunov DP.
    Psychopharmacology (Berl); 2006 Jun 14; 186(3):351-61. PubMed ID: 16249906
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.